BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) announced that nutritionist and Harvard-trained scientist John Paul SanGiovanni has joined the company’s medical and scientific advisory board.
SanGiovanni directs the Center for the Study of Nutrient-Responsive Systems and leads the Food and Nutrition Branch of the National Science Foundation Industry-University Center for Collaborative Research, Center for Streaming Healthcare in Place.
In his advisory role, he will serve as a liaison between the company and entities in academia, industry and government, introducing the company’s biotech capabilities to potential research partners and facilitating applications for grants in the US and Europe.
"Dr. SanGiovanni's teams are researching the different mechanisms that allow the human body to transport, sense, and metabolize vital nutrients,” CEO Ilan Sobel said in a statement. “He is a fierce advocate for the need to identify the plant based solutions that can best enhance human health, extend lives, and reduce illness and disability.”
He continued, "We envision John Paul working closely with Dr. Cornblatt and our Science team to help identify the global research initiatives best suited to benefit from our Botanical Synthesis technology, and we also see him as a critical partner in our mission to educate academia and the health verticals on the potential of Botanical Synthesis to improve the human experience."
BioHarvest, based in Vancouver, has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at an industrial scale, without the need to grow the plant itself.
"Through its Bio-Cellicitation platform, the BioHarvest team has eliminated variations in product quality otherwise linked to climate, pest exposures, and soil/water chemistry -- the portability of the BioHarvest technology opens global vistas for controlled growing environments in any space with the capacity to hold their bioreactors," SanGiovanni said.
"This will promote production of high-quality nutrient and food constituents to industry and consumers, and the efficiency by which the end-to-end ecosystem operating in the ISO-/GMP-compliant BioHarvest Botanical Synthesis process yields an abundance of consistent, clean and market-ready plant-based bioactive compounds is unparalleled."
Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com
Follow him on Twitter @andrew_kessel